pre-Calcitriol PTAD Adduct (Mixture of Diastereomers)
CAS: 86307-44-0
Ref. TR-C144520
| 1mg | 430.00 € | ||
| 10mg | 2,244.00 € | ||
| 2500µg | 925.00 € |
Estimated delivery in United States, on Tuesday 15 Oct 2024
Product Information
Name:
pre-Calcitriol PTAD Adduct (Mixture of Diastereomers)
Controlled Product
Synonyms:
- [4aR-[4aα,6aα,7α(R*),9aβ,11α(3S*,5R*)]]-11-(3,5-Dihydroxy-2-methyl-1-cyclohexen-1-yl)-4a,6,6a,7,8,9,9a,11-octahydro-7-(5-hydroxy-1,5-dimethylhexyl)-6a-methyl-2-phenyl-1H,5H-cyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione
- Triazoline adduct of Pre-calcitriol
Description:
Applications Calcitriol (C144500) impurity. 1α-Hydroxyvitamin D and 1α-hydroxyprevitamin D compounds were prepared in multistep syntheses via hydroxylation of previtamin D compound adducts with dienophiles.
References Vanmaele, L., et al.: Tetrahedron, 41, 141 (1985),
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
591.78
Formula:
C35H49N3O5
Color/Form:
White To Off-White
InChI:
InChI=1S/C35H49N3O5/c1-21(10-9-16-34(3,4)43)27-13-14-28-26-20-30(25-18-24(39)19-31(40)22(25)2)38-33(42)36(23-11-7-6-8-12-23)32(41)37(38)29(26)15-17-35(27,28)5/h6-8,11-12,20-21,24,27-31,39-40,43H,9-10,13-19H2,1-5H3/t21-,24-,27-,28+,29-,30+,31+,35-/m1/s1
InChI key:
InChIKey=AYDPRRXRNSGAGP-ZBKKTSFSSA-N
SMILES:
CC1=C([C@@H]2C=C3[C@@H](CC[C@@]4(C)[C@H]3CC[C@@H]4[C@H](C)CCCC(C)(C)O)n3c(=O)n(-c4ccccc4)c(=O)n32)C[C@@H](O)C[C@@H]1O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-C144520 pre-Calcitriol PTAD Adduct (Mixture of Diastereomers)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
